FIELD: medicine.
SUBSTANCE: composition having a gel-like consistency contains metronidazole, terconazole, a physiologically acceptable thickener and water.
EFFECT: composition is applicable for treating bacterial vaginosis, as well as vulvovaginal candidiasis.
4 cl, 2 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION AND METHOD FOR TREATING VAGINITIS | 1991 |
|
RU2032402C1 |
| AGENT AND METHOD FOR TREATMENT OF BACTERIAL VAGINITIS | 2004 |
|
RU2261715C1 |
| METHOD OF TREATING BACTERIAL VAGINOSIS | 2009 |
|
RU2393870C1 |
| METHOD FOR LOCAL TREATMENT OF BACTERIAL VAGINOSIS | 2003 |
|
RU2236851C1 |
| USING LACTIC ACID OLIGOMERS IN TREATING GYNAECOLOGICAL DISORDERS | 2008 |
|
RU2459620C2 |
| METHOD FOR TREATMENT OF RECURRENT BACTERIAL VAGINOSIS IN WOMEN INFECTED WITH HERPES SIMPLEX VIRUS | 2021 |
|
RU2770293C1 |
| DRUG DELIVERY POLYMER WITH CLINDAMYCIN HYDROCHLORIDE | 2007 |
|
RU2444364C2 |
| USE OF TOTAROL AND PHARMACEUTICAL COMPOSITION CONTAINING TOTAROL | 2018 |
|
RU2812223C2 |
| MEDICINAL PREPARATION AND METHOD OF UROGENITAL INFECTION PROPHYLAXIS AND TREATMENT | 1996 |
|
RU2073520C1 |
| PHARMACEUTICAL COMPOSITION SUITABLE FOR INTRAVAGINAL DELIVERY | 2021 |
|
RU2828262C1 |
Authors
Dates
2025-02-19—Published
2021-04-22—Filed